Zhejiang Shengda Bio-Pharm Co., Ltd.
SSE:603079.SS
16.54 (CNY) • At close June 12, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2015 Q2 | 2015 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 203.226 | 218.532 | 224.395 | 197.111 | 182.583 | 183.297 | 181.078 | 193.751 | 169.279 | 202.109 | 185.469 | 165.275 | 185.166 | 210.02 | 189.577 | 198.205 | 191.931 | 200.435 | 216.441 | 253.9 | 196.539 | 145.223 | 122.995 | 129.74 | 121.191 | 138.082 | 140.232 | 96.435 | 117.96 | 138.955 | 118.882 | 133.998 | 116.726 | 101.073 | 103.181 | 160.531 | 160.531 |
| Cost of Revenue
| 144.5 | 165.534 | 178.35 | 163.346 | 147.712 | 162.39 | 148.561 | 162.446 | 137.554 | 195.348 | 151.786 | 125.524 | 134.515 | 150.022 | 133.795 | 139.601 | 137.854 | 110.125 | 100.408 | 93.011 | 90.191 | 81.574 | 78.161 | 86.318 | 80.567 | 100.419 | 97.353 | 66.845 | 62.789 | 77.433 | 72.161 | 87.458 | 79.196 | 68.711 | 63.529 | 69.52 | 69.52 |
| Gross Profit
| 58.725 | 52.997 | 46.045 | 33.765 | 34.87 | 20.907 | 32.517 | 31.306 | 31.725 | 6.76 | 33.683 | 39.751 | 50.651 | 59.998 | 55.782 | 58.604 | 54.077 | 90.31 | 116.033 | 160.889 | 106.348 | 63.65 | 44.833 | 43.423 | 40.624 | 37.664 | 42.88 | 29.59 | 55.171 | 61.522 | 46.721 | 46.54 | 37.53 | 32.362 | 39.651 | 91.011 | 91.011 |
| Gross Profit Ratio
| 0.289 | 0.243 | 0.205 | 0.171 | 0.191 | 0.114 | 0.18 | 0.162 | 0.187 | 0.033 | 0.182 | 0.241 | 0.274 | 0.286 | 0.294 | 0.296 | 0.282 | 0.451 | 0.536 | 0.634 | 0.541 | 0.438 | 0.365 | 0.335 | 0.335 | 0.273 | 0.306 | 0.307 | 0.468 | 0.443 | 0.393 | 0.347 | 0.322 | 0.32 | 0.384 | 0.567 | 0.567 |
| Reseach & Development Expenses
| 10.163 | 14.737 | 10.219 | 10.29 | 7.897 | 12.739 | 8.97 | 12.023 | 9.192 | 9.197 | 8.358 | 12.667 | 7.196 | 11.603 | 8.512 | 11.287 | 8.241 | 9.153 | 10.136 | 11.766 | 4.631 | 9.461 | 8.278 | 5.65 | 4.513 | 6.608 | 4.541 | 16.448 | 4.026 | 31.349 | 5.223 | 9.184 | 0 | 23.905 | 0 | 5.379 | 5.379 |
| General & Administrative Expenses
| 14.865 | -31.761 | 41.467 | -9.549 | 17.752 | -38.191 | 45.867 | -10.027 | 17.501 | -52.546 | 55.662 | -6.802 | 17.718 | -33.201 | 58.319 | -11.47 | 21.248 | -31.411 | 33.162 | -3.929 | 21.569 | -26.988 | 21.357 | -3.597 | 13.935 | -22.196 | 18.68 | -9.202 | 15.673 | -28.593 | 18.523 | -9.71 | 14.863 | -41.74 | 25.389 | 19.106 | 19.106 |
| Selling & Marketing Expenses
| 2.669 | -3.325 | 7.675 | 3.715 | 2.77 | 4.501 | 3.059 | 3.653 | 2.991 | 2.977 | 3.793 | 3.65 | 2.829 | 5.36 | 2.768 | 3.074 | 1.27 | 2.772 | 8.376 | 12.456 | 4.978 | 7.049 | 3.535 | 3.297 | 4.616 | 5.5 | 5.968 | 3.349 | 2.305 | 6.515 | 4.011 | 1.659 | 3.143 | 3.363 | 7.049 | 4.731 | 4.731 |
| SG&A
| 17.534 | -35.086 | 49.142 | 18.751 | 21.378 | -33.69 | 48.926 | -6.374 | 20.491 | -49.569 | 59.456 | -3.152 | 20.547 | -27.841 | 61.088 | -8.397 | 22.517 | -28.639 | 41.539 | 8.527 | 26.547 | -19.938 | 24.891 | -0.301 | 18.551 | -16.697 | 24.647 | -5.853 | 17.978 | -22.078 | 22.534 | -8.051 | 18.006 | -38.377 | 32.438 | 25.868 | 25.868 |
| Other Expenses
| 3.395 | 55.005 | -24.188 | -3.201 | -2.71 | 1.447 | -0.28 | -0.496 | -2.741 | 51.047 | -30.829 | 26.543 | -2.817 | 0.67 | -2.3 | 0.041 | 0.187 | -20.277 | -0.648 | -1.831 | -0.875 | -0.414 | -0.994 | -0.068 | -0.031 | 1.822 | -0.069 | 0.522 | -0.107 | -10.952 | 0.893 | 8.757 | 0.214 | 0.516 | 0.999 | 0 | 0 |
| Operating Expenses
| 31.092 | 34.655 | 35.172 | 32.242 | 31.985 | 26.19 | 30.121 | 35.952 | 26.943 | 10.675 | 36.985 | 36.059 | 24.926 | 50.398 | 38.566 | 35.071 | 28.223 | 52.649 | 53.069 | 56.456 | 30.045 | 41.161 | 34.288 | 26.182 | 19.946 | 35.656 | 30.243 | 21.63 | 19.384 | 28.436 | 24.046 | 17.244 | 19.025 | 30.276 | 33.258 | 32.834 | 32.834 |
| Operating Income
| 27.633 | 18.342 | 10.873 | 1.522 | 2.885 | -51.816 | 5.288 | -5.025 | 5.877 | -17.468 | 7.902 | 22.183 | 23.531 | 12.096 | 19.361 | 25.292 | 24.695 | 13.027 | 56.363 | 104.28 | 73.636 | 0.844 | 12.532 | 20.128 | 17.178 | -9.201 | 16.486 | 16.057 | 28.957 | 27.389 | 18.374 | 23.999 | 16.058 | 7.991 | 7.84 | 63.544 | 63.544 |
| Operating Income Ratio
| 0.136 | 0.084 | 0.048 | 0.008 | 0.016 | -0.283 | 0.029 | -0.026 | 0.035 | -0.086 | 0.043 | 0.134 | 0.127 | 0.058 | 0.102 | 0.128 | 0.129 | 0.065 | 0.26 | 0.411 | 0.375 | 0.006 | 0.102 | 0.155 | 0.142 | -0.067 | 0.118 | 0.167 | 0.245 | 0.197 | 0.155 | 0.179 | 0.138 | 0.079 | 0.076 | 0.396 | 0.396 |
| Total Other Income Expenses Net
| 0.103 | -4.464 | 0.141 | 6.778 | 4.683 | 1.447 | -0.28 | -0.496 | -0.302 | -0.004 | 0.129 | 0.104 | 0.145 | 0.67 | -2.3 | 0.041 | 0.187 | -20.277 | -0.648 | -1.831 | -0.875 | -0.414 | -0.994 | -0.068 | -0.031 | 0.845 | -0.069 | -0.569 | -0.107 | -9.975 | 0.893 | 9.014 | 0.214 | -0.539 | 0.999 | -0.414 | -0.414 |
| Income Before Tax
| 27.736 | 13.878 | 11.014 | 16.624 | 7.569 | -50.37 | 5.008 | -5.521 | 5.575 | -17.471 | 8.031 | 22.287 | 23.677 | 12.765 | 17.061 | 25.333 | 24.882 | -7.251 | 55.715 | 102.449 | 72.761 | 0.43 | 11.539 | 20.06 | 17.147 | -8.356 | 16.417 | 15.487 | 28.85 | 17.414 | 19.268 | 33.012 | 16.272 | 7.452 | 8.838 | 56.794 | 56.794 |
| Income Before Tax Ratio
| 0.136 | 0.064 | 0.049 | 0.084 | 0.041 | -0.275 | 0.028 | -0.028 | 0.033 | -0.086 | 0.043 | 0.135 | 0.128 | 0.061 | 0.09 | 0.128 | 0.13 | -0.036 | 0.257 | 0.404 | 0.37 | 0.003 | 0.094 | 0.155 | 0.141 | -0.061 | 0.117 | 0.161 | 0.245 | 0.125 | 0.162 | 0.246 | 0.139 | 0.074 | 0.086 | 0.354 | 0.354 |
| Income Tax Expense
| 4.317 | 4.03 | 3.083 | 2.45 | 2.265 | 1.205 | 1.584 | 3.8 | 2.304 | -2.965 | 2.245 | 3.522 | 3.281 | 0.664 | 2.97 | 1.767 | 2.818 | -0.175 | 8.625 | 13.053 | 12.199 | 3.842 | 2.997 | 1.95 | 2.627 | 0.773 | 2.062 | 2.181 | 4.8 | 2.408 | 3.305 | 4.458 | 3.185 | 0.747 | 2.631 | 9.238 | 9.238 |
| Net Income
| 21.709 | 7.745 | 5.184 | 12.682 | 3.813 | -50.375 | 2.645 | -9.824 | 3.491 | -14.507 | 6.061 | 19.132 | 20.8 | 11.785 | 16.081 | 24.501 | 23.389 | -2.968 | 48.977 | 89.001 | 62.428 | 2.376 | 10.671 | 19.87 | 14.112 | -7.168 | 14.356 | 13.306 | 24.05 | 15.007 | 15.962 | 28.554 | 13.088 | 6.705 | 6.207 | 47.556 | 47.556 |
| Net Income Ratio
| 0.107 | 0.035 | 0.023 | 0.064 | 0.021 | -0.275 | 0.015 | -0.051 | 0.021 | -0.072 | 0.033 | 0.116 | 0.112 | 0.056 | 0.085 | 0.124 | 0.122 | -0.015 | 0.226 | 0.351 | 0.318 | 0.016 | 0.087 | 0.153 | 0.116 | -0.052 | 0.102 | 0.138 | 0.204 | 0.108 | 0.134 | 0.213 | 0.112 | 0.066 | 0.06 | 0.296 | 0.296 |
| EPS
| 0.13 | 0.046 | 0.031 | 0.075 | 0.022 | -0.41 | 0.016 | -0.057 | 0.02 | -0.085 | 0.035 | 0.11 | 0.12 | 0.069 | 0.096 | 0.15 | 0.14 | -0.018 | 0.29 | 0.54 | 0.38 | 0.016 | 0.06 | 0.13 | 0.093 | -0.047 | 0.093 | 0.085 | 0.15 | 0.12 | 0.12 | 0.24 | 0.11 | 0.055 | 0.051 | 0.41 | 0.41 |
| EPS Diluted
| 0.13 | 0.046 | 0.031 | 0.075 | 0.022 | -0.41 | 0.016 | -0.057 | 0.02 | -0.085 | 0.035 | 0.11 | 0.12 | 0.069 | 0.096 | 0.15 | 0.14 | -0.018 | 0.27 | 0.54 | 0.35 | 0.016 | 0.06 | 0.13 | 0.093 | -0.046 | 0.093 | 0.085 | 0.15 | 0.12 | 0.12 | 0.24 | 0.11 | 0.055 | 0.051 | 0.41 | 0.41 |
| EBITDA
| 27.987 | 14.854 | 11.266 | 36.333 | 25.43 | -29.873 | 25.449 | 1.077 | 24.78 | 0.525 | 28.2 | 41.517 | 43.532 | 33.743 | 37.846 | 46.346 | 45.094 | 4.432 | 57.226 | 119.739 | 85.655 | 4.351 | 14.436 | 34.105 | 28.935 | 4.948 | 18.015 | 10.848 | 35.003 | 20.505 | 22.458 | 33.33 | 19.404 | 22.486 | 6.393 | 66.753 | 66.753 |
| EBITDA Ratio
| 0.138 | 0.068 | 0.05 | 0.184 | 0.139 | -0.163 | 0.141 | 0.006 | 0.146 | 0.003 | 0.152 | 0.251 | 0.235 | 0.161 | 0.2 | 0.234 | 0.235 | 0.022 | 0.264 | 0.472 | 0.436 | 0.03 | 0.117 | 0.263 | 0.239 | 0.036 | 0.128 | 0.112 | 0.297 | 0.148 | 0.189 | 0.249 | 0.166 | 0.222 | 0.062 | 0.416 | 0.416 |